NCT02678052View on ClinicalTrials.gov

OTIS Vedolizumab Pregnancy Exposure Registry

CompletedOBSERVATIONAL
Enrollment

303

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

July 15, 2022

Study Completion Date

July 31, 2022

Conditions
Colitis, UlcerativeCrohn's Disease
Interventions
DRUG

Vedolizumab

Vedolizumab exposure

BIOLOGICAL

Other Biological Agent

Other Biological Agent exposure

Trial Locations (1)

Unknown

San Diego

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
collaborator

The Organization of Teratology Information Specialists

OTHER

lead

Takeda

INDUSTRY